Latest Articles

  • Detecting and controlling diabetic nephropathy: What do we know?
    Gerald Appel, MD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 209-217; DOI: https://doi.org/10.3949/ccjm.80gr.12006

    Diabetic kidney disease is on the rise. Strategies to prevent or control it are lowering blood pressure, controlling blood sugar, and inhibiting the renin-angiotensin-aldosterone system.

  • Resistance of man and bug
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 202; DOI: https://doi.org/10.3949/ccjm.80b.04013

    Why individual clinicians make specific decisions usually can be sorted out. But our behavior as a group is more difficult to understand—and to alter.

  • In Reply: Short QT syndrome (January 2013)
    Hayan Al Maluli, MD and Arnold B. Meshkov, MD, MBA, FACC
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 203; DOI: https://doi.org/10.3949/ccjm.80c.04002

    Readers comment on the short QT syndrome (January 2013).

  • What should be the interval between bone density screenings?
    Susan M. Ott, MD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 240-242; DOI: https://doi.org/10.3949/ccjm.80a.12166

    Doctors should not order unnecessary and expensive tests and should not recommend frequent repeated testing that does not benefit the patient.

  • Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients
    Federico Perez, MD and David Van Duin, MD, PhD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 225-233; DOI: https://doi.org/10.3949/ccjm.80a.12182

    The emergence of carbapenem-resistant Enterobacteriaceae (CRE) highlights the importance of effective antibiotics to maintain the safety of our health care system. Clinicians will encounter CRE as a cause of difficult-to-treat and often fatal infections in hospitalized patients. We review the mechanisms of carbapenem resistance, the dissemination and clinical impact of these resistant organisms, and challenges to their detection, treatment, and control.

  • Options for managing severe aortic stenosis: A case-based review
    Options for managing severe aortic stenosis: A case-based review
    Olcay Aksoy, MD, Bridget L. O’brien, MD, FACC and Venu Menon, MD, FACC, FAHA
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 243-252; DOI: https://doi.org/10.3949/ccjm.80a.12078

    Today, patients who cannot undergo surgery can be offered a variety of less invasive treatments. We use seven cases to illustrate how to manage these patients.

  • Giant inverted T waves
    Surabhi Madhwal, MD, Vijaiganesh Nagarajan, MD, MRCP, FACP and Donald A. Underwood, MD
    Cleveland Clinic Journal of Medicine March 2013, 80 (3) 138-139; DOI: https://doi.org/10.3949/ccjm.80a.11139

    A 48-year-old man has large, inverted T waves in the lateral and midprecordial leads. What is the cause?

  • Emergency contraception (November 2012)
    Chris Kahlenborn, MD and Walter B. Severs, PhD, FCP
    Cleveland Clinic Journal of Medicine March 2013, 80 (3) 185; DOI: https://doi.org/10.3949/ccjm.80c.03001

    Readers comment on emergency contraception (November 2012), adrenal masses (December 2012), and the use of statins for primary prevention in women (December 2012).

  • A 67-year old man with an abdominal aortic aneurysm
    A 67-year old man with an abdominal aortic aneurysm
    Allison LaBoon, MD and Tara Marie Mastracci, MD, MSc, FRCSC
    Cleveland Clinic Journal of Medicine March 2013, 80 (3) 161-167; DOI: https://doi.org/10.3949/ccjm.80a.12156

    Who should be screened, what is the benefit, and how should patients found to have an aneurysm be treated?

  • Sex, statins, and diabetes (December 2012)
    Holly L. Thacker, MD, FACP, NCMP, CCD
    Cleveland Clinic Journal of Medicine March 2013, 80 (3) 187; DOI: https://doi.org/10.3949/ccjm.80c.03004

    Readers comment on emergency contraception (November 2012), adrenal masses (December 2012), and the use of statins for primary prevention in women (December 2012).

Pages